In general, drug administration devices configured to communicate with networks and external devices are provided. In an exemplary embodiment, a drug administration device is configured to adjust an operational parameter of the drug administration device based on a data packet formed from drug administration data ancillary data received from networks and/or external devices. In another example embodiment, a drug administration device is configured to scan for and establish communications with at least one external device. In another example embodiment, a method includes assessing whether to update a control program on a drug administration device from a network or external device. In another example embodiment, a system includes a first drug administration device configured to communicate with a second drug administration device to optimize a drug treatment.

An aerosolization system includes a container that is configured to deliver a unit dosage of a liquid when squeezed a single time. The system also includes an aerosolizer that is constructed of a housing defining a mouthpiece, and an aerosol generator disposed in the housing. The aerosol generator includes a vibratable membrane having a front face and a rear face, and a vibratable element used to vibrate the membrane. Further, the housing includes an opening that is adapted to receive a unit dosage of the liquid from the container. The opening provides a liquid path to the rear face of the vibratable membrane.

The present invention provides for the integration of drug dispersion methods into a drug or medicine delivery system. The drug dispersion methods used include shear (e.g., air across a drug, with or without a gas assist), capillary flow or a venturi effect, mechanical means such as spinning, vibration, or impaction, and turbulence (e.g., using mesh screens, or restrictions in the air path). These methods of drug dispersion allow for all of the drug in the system to be released, allowing control of the dosage size. These methods also provide for drug metering, fluidization, entrainment, deaggragation and deagglomeration. The present invention also provides for the integration of a drug sealing system into the device. The drug sealing system provides a way of blocking the migration of drug from one area of the package to another. The drug seal system can also provide a method of tightly containing the drug until the package is opened, of directing airflow through the package and of managing and containing the drug during the package/device manufacturing process.

Provided is a system comprising at least one inhaler. Each of the at least one inhaler comprises a use determination system configured to determine at least one value of a usage parameter relating to use of the respective inhaler by a subject. The system further comprises a user interface and a processing module. The user interface is configured to enable user-inputting of an indication of a status of a respiratory disease being experienced by the subject. The processing module is configured to control the user interface to issue a prompt to input the indication based on the at least one value.

A method for treating patients with COVID-19 and/or other respiratory conditions includes administering eighty-five milligrams of dapsone twice daily for twenty-one days. A variety of dapsone formulations and delivery devices are disclosed, including an inhaler, nasal spray, nasal gel, otic formulation, intravenous formulation, oral solution, oral suspension, patch and suppository.

A metered dose inhaler includes ring body open at both ends, the ring body adapted to house a pressurized canister of medicine, an actuator ring including two or more external spring housings containing springs seated and aligned with spring seats formed on a cap attached to the distal end of the ring body the actuator ring fitting over the ring body in concentric fashion partially housing the ring body, the actuator ring having an actuator form fixed to an inside surface thereof to actuate a canister stem installed on the pressurized canister by urging the actuator ring against spring tension over the ring body toward the cap displacing a canister stem to break seal and dispense a dose of medicine.

The invention relates to the field of inhalation devices for liquids. In particular, the invention relates to an inhalation device having improved flow characteristics. A inhalation device for medically active liquids (F) for generation of an aerosol comprises a housing (1), inside this housing (1) a reservoir (2) for storing a liquid (F), a pumping device with a hollow cylinder (9) providing a pumping chamber (3) for the generation of a pressure inside said pumping chamber (3), wherein the pumping chamber is fluidically connected with the reservoir (2) via an inlet check valve (4) which blocks in direction of the reservoir (2), a riser pipe (5) which can be received with at least one reservoir-facing, interior end (5A) in said hollow cylinder (9), and a nozzle (6) which is connected liquid-tight to an exterior end (5B) of the riser pipe (5), wherein the volume of the pumping chamber (3) is changeable by means of relative motion of the cylinder (9) to the riser pipe (5), and is characterised in that the riser pipe (5) is immobile and firmly attached to the housing (1) and to the nozzle (6), whereas the hollow cylinder (9) is moveable relative to the housing (1) and to the nozzle (6). The invention also discloses a method for the generation of an aerosol of a medically active liquid (F) by means of an inhalation device.

Provided is a system and method for a vaporizer cartridge system wherein the cartridge provides the diffuser. More specifically, an embodiment of the system includes a vaporizing device providing a heating element proximate to a removable cartridge system receiving port, and a dispenser trigger structured and arranged to engage the removable cartridge to dispense a predetermined amount of a liquid concentrate from within the removable cartridge. The system further includes a cartridge with diffuser including: a housing; a reservoir of liquid concentrate; a diffuser element; a metered dispenser structured and arranged to dispense from the reservoir into the diffuser element a predetermined amount of liquid concentrate. An associated method of use is also provided.

A opioid overdose treatment assembly for treating an opioid overdose includes a housing that can be worn on a user. An inhaler is coupled to the housing and the inhaler contains an aerosolized medication for treating an opioid overdose. The inhaler is actuatable to release a pre-determined amount of the aerosolized medication for inhalation by the user when the user is suffering from an opioid overdose. A communicator is coupled to the housing and the communicator is in wireless communication with a communication network. In this way the communicator can be placed in communication with emergency responders.

An atomizer is disclosed. The atomizer includes: a pump housing including an internal chamber extending in an axial direction of the pump housing and a mounting seat disposed at a first end of the pump housing and being in communication with the internal chamber; a seal disposed in the mounting seat, the seal including a sealing sleeve and a first bore in the sealing sleeve and coaxial with the internal chamber, and at least a part of the seal resting against a mounting surface of the mounting seat; a pressing member at least partially disposed within the mounting seat and resting against the seal to press and keep the seal in the mounting seat, the pressing member including a second bore coaxial with the internal chamber; and a plunger, a first end of the plunger being disposed within the internal chamber of the pump housing through the second bore of the pressing member and the first bore of the seal, and the first end of the plunger being capable of reciprocating in the internal chamber to pump fluid in or out of the internal chamber; wherein the pump housing, the pressing member and the plunger together define a sealing cavity to accommodate the seal.